Filing Flows › CorMedix (CRMD) › Who owns the stock
Who owns CorMedix (CRMD) stock
181 funds reported CorMedix (CRMD) shares in their latest 13F filings, worth $389M in all. The largest holder is Vanguard Group ($52.3M). Last quarter 87 funds added to their stakes and 70 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 4,499,010 | $52.3M | increase | 2025-12-31 |
| BlackRock | 6,324,111 | $49.6M | increase | 2026-06-30 |
| Deep Track Capital, LP | 6,274,076 | $49.3M | unchanged | 2026-06-30 |
| Vanguard Capital Management LLC | 3,135,075 | $24.6M | increase | 2026-06-30 |
| State Street | 2,316,845 | $18.2M | increase | 2026-06-30 |
| Royce & Associates LP | 2,176,362 | $17.1M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 1,947,014 | $15.3M | increase | 2026-06-30 |
| UBS Group AG | 1,877,940 | $14.7M | increase | 2026-06-30 |
| Oberweis Asset Management | 1,323,915 | $10.4M | increase | 2026-06-30 |
| Alyeska Investment Group, L.P. | 850,000 | $6.7M | unchanged | 2026-06-30 |
| Marshall Wace, LLP | 779,535 | $6.1M | increase | 2026-06-30 |
| Northern Trust | 756,430 | $5.9M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 708,604 | $5.6M | decrease | 2026-06-30 |
| Pacer Advisors | 633,978 | $5.0M | increase | 2026-06-30 |
| Trexquant Investment LP | 623,797 | $4.9M | increase | 2026-06-30 |
CorMedix's latest quarter
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CRMD stock?
By the latest 13F filings: Vanguard Group ($52.3M); BlackRock ($49.6M); Deep Track Capital, LP ($49.3M); Vanguard Capital Management LLC ($24.6M); State Street ($18.2M).
What is the short interest in CRMD?
14,665,697 shares were sold short at the 2026-10-15 settlement, -4.91% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.